Clinical Trial Update: [68Ga]Ga-PSMA PET/CT in Hepatocellular Carcinoma: Impact of Multiparametric Dynamic Whole-body Imaging and Kinetic Modeling. [NA]

View source ↗

Summary

A clinical trial evaluating Gallium-68 PSMA PET/CT imaging in hepatocellular carcinoma, focusing on multiparametric dynamic whole-body imaging and kinetic model…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• [68Ga]Ga-PSMA (Gallium-68 labeled PSMA ligand)

Snippet

Sponsor: Nantes University Hospital | Conditions: HCC - Hepatocellular Carcinoma | NA | Status: RECRUITING